Structure, function, and allosteric modulation of NMDA receptors

  • Kasper B. Hansen
  • , Feng Yi
  • , Riley E. Perszyk
  • , Hiro Furukawa
  • , Lonnie P. Wollmuth
  • , Alasdair J. Gibb
  • , Stephen F. Traynelis

Research output: Contribution to journalReview articlepeer-review

465 Scopus citations

Abstract

NMDA-type glutamate receptors are ligand-gated ion channels that mediate a Ca2+-permeable component of excitatory neurotransmission in the central nervous system (CNS). They are expressed throughout the CNS and play key physiological roles in synaptic function, such as synaptic plasticity, learning, and memory. NMDA receptors are also implicated in the pathophysiology of several CNS disorders and more recently have been identified as a locus for disease-associated genomic variation. NMDA receptors exist as a diverse array of subtypes formed by variation in assembly of seven subunits (GluN1, GluN2A-D, and GluN3A-B) into tetrameric receptor complexes. These NMDA receptor subtypes show unique structural features that account for their distinct functional and pharmacological properties allowing precise tuning of their physiological roles. Here, we review the relationship between NMDA receptor structure and function with an emphasis on emerging atomic resolution structures, which begin to explain unique features of this receptor.

Original languageEnglish
Pages (from-to)1081-1105
Number of pages25
JournalJournal of General Physiology
Volume150
Issue number8
DOIs
StatePublished - Aug 1 2018

Funding

This work was supported by grants from National Institutes of Health to S.F. Traynelis (NS036654 and NS065371), K.B. Hansen (GM103546 and NS097536), and L.P. Wollmuth (NS088479). S.F. Traynelis is a consultant for Janssen Pharmaceuticals, Inc., the principal investigator on a research grant awarded to Emory University from Janssen Pharmaceuticals, a member of the Scientific Advisory Board for Sage Therapeutics, and co-founder of NeurOp, Inc. K.B. Hansen is the principal investigator on a research grant awarded to University of Montana from Janssen Pharmaceuticals. The other authors declare no competing financial interests. Author contributions: All authors wrote the manuscript. Lesley C. Anson served as editor.

Funder number
NS036654, NS065371
R01MH085926

    Fingerprint

    Dive into the research topics of 'Structure, function, and allosteric modulation of NMDA receptors'. Together they form a unique fingerprint.

    Cite this